SEC Filings - MiNK Therapeutics

Form	Description	Filing date	View
4	Statement of changes in beneficial ownership of securities	May 04, 2023	View HTML 0000950170-23-018042.pdf 0000950170-23-018042.rtf 0000950170-23-018042.xls
SC 13D/A	An amendment to a SC 13D filing	May 03, 2023	View HTML 0001193125-23-134576.pdf 0001193125-23-134576.rtf 0001193125-23-134576.xls
4	Statement of changes in beneficial ownership of securities	May 03, 2023	View HTML 0000899243-23-012119.pdf 0000899243-23-012119.rtf 0000899243-23-012119.xls
DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	May 01, 2023	View HTML 0000950170-23-016187.pdf 0000950170-23-016187.rtf 0000950170-23-016187.xls
10-K	Annual report which provides a comprehensive overview of the company for the past year	Mar 24, 2023	View HTML 0000950170-23-009762.pdf 0000950170-23-009762.rtf 0000950170-23-009762.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-K	Report of unscheduled material events or corporate event	Mar 21, 2023	View HTML 0001171843-23-001783.pdf 0001171843-23-001783.rtf 0001171843-23-001783.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
4	Statement of changes in beneficial ownership of securities	Mar 03, 2023	View HTML 0000899243-23-006912.pdf 0000899243-23-006912.rtf 0000899243-23-006912.xls
4	Statement of changes in beneficial ownership of securities	Mar 03, 2023	View HTML 0000899243-23-006913.pdf 0000899243-23-006913.rtf 0000899243-23-006913.xls
4	Statement of changes in beneficial ownership of securities	Mar 03, 2023	View HTML 0000899243-23-006915.pdf 0000899243-23-006915.rtf 0000899243-23-006915.xls
4	Statement of changes in beneficial ownership of securities	Mar 03, 2023	View HTML 0000899243-23-006922.pdf 0000899243-23-006922.rtf 0000899243-23-006922.xls

Data provided by Kaleidoscope.